IDEXX Laboratories Inc (IDXX) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Total Assets Chart for IDEXX Laboratories Inc
IDEXX Laboratories Inc (IDXX) total assets for FY2025 were USD 3.4B, a 1.7% change from FY2024. IDEXX Laboratories Inc's total assets grew from USD 38.1M in 1991 to USD 3.4B in 2025 (8694.6% over 34 years). Total assets compound annual growth rate: 5-year CAGR of 7.9%, 10-year CAGR of 8.6%, 20-year CAGR of 10.1%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $46.54B
- Implied Share Price
- $590.00
- Enterprise Value
- $47.30B
- Revenue (TTM)
- $4.55B
- EBITDA
- $1.62B
- Profit Margin
- 25.03%
- Trailing P/E
- 41.14
- Forward P/E
- 39.84
- Price/Book (MRQ)
- 29.81
- Price/Sales (TTM)
- 10.21
- EV/EBITDA
- 30.37
- EV/Revenue
- 10.64
- Dividend Yield
- —
- Book Value
- $19.64
- Free Cash Flow (FY2025)
- $1.05B
- Free Cash Flow Yield
- 2.26%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.